Narda Whiting‐Theobald

1.4k citations

20 papers · 779 indexed · h-index 14

Co-authors: Harry L. Malech Gilda F. Linton Uimook Choi Toshinao Kawai Sebastian Brenner Philip M. Murphy Suk See De Ravin Joan M. G. Sechler
Topics: Virus-based gene therapy research (14 papers)CAR-T cell therapy research (10 papers)RNA Interference and Gene Delivery (6 papers)
Cited by: Immunology Genetics Oncology
Journals: Blood Stem Cells Molecular Therapy
Partner nations: United States Germany Japan

In The Last Decade

Narda Whiting‐Theobald

20 papers receiving 762 citations

Peers

Countries citing papers authored by Narda Whiting‐Theobald

Since Specialization

Citations

This map shows the geographic impact of Narda Whiting‐Theobald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narda Whiting‐Theobald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narda Whiting‐Theobald more than expected).

Fields of papers citing papers by Narda Whiting‐Theobald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narda Whiting‐Theobald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narda Whiting‐Theobald. The network helps show where Narda Whiting‐Theobald may publish in the future.

Co-authorship network of co-authors of Narda Whiting‐Theobald

This figure shows the co-authorship network connecting the top 25 collaborators of Narda Whiting‐Theobald. A scholar is included among the top collaborators of Narda Whiting‐Theobald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narda Whiting‐Theobald. Narda Whiting‐Theobald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypomorphic Rag mutations can cause destructive midline granulomatous disease 2010 ·Blood ·Suk See De Ravin,Edward W. Cowen,Kol A. Zarember,Narda Whiting‐Theobald,Douglas B. Kuhns,Netanya G. Sandler,Daniel C. Douek,Stefania Pittaluga,Pietro Luigi Poliani,Yu Nee Lee,Luigi D. Notarangelo,(unknown),Frederick W. Alt,Elizabeth M. Kang,Joshua D. Milner,Julie E. Niemela,(unknown),Sara H. Sinal,Harry L. Malech	76
2	Update on gene therapy for Chronic Granulomatous Disease: Current studies and future approaches 2008 ·Blood Cells Molecules and Diseases ·Harry L. Malech,Gilda F. Linton,Narda Whiting‐Theobald,Nora Naumann,Suk See De Ravin,Uimook Choi,Morvarid Moayeri,(unknown),Dianne Hilligoss,Yasuhiro Ikeda,Elizabeth M. Kang	2
3	Diprotin A Infusion into Nonobese Diabetic/Severe Combined Immunodeficiency Mice Markedly Enhances Engraftment of Human Mobilized CD34 ⁺ Peripheral Blood Cells 2007 ·Stem Cells and Development ·Toshinao Kawai,Uimook Choi,(unknown),Narda Whiting‐Theobald,Gilda F. Linton,Harry L. Malech	37
4	Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft 2007 ·Gene Therapy ·Nora Naumann,Suk See De Ravin,Uimook Choi,Morvarid Moayeri,Narda Whiting‐Theobald,(unknown),Yasuhiro Ikeda,Harry L. Malech	21
5	The Late Dividing Population of γ‐Retroviral Vector Transduced Human Mobilized Peripheral Blood Progenitor Cells Contributes Most to Gene‐Marked Cell Engraftment in Nonobese Diabetic/Severe Combined Immunodeficient Mice 2007 ·Stem Cells ·Sebastian Brenner,Martin Ryser,Narda Whiting‐Theobald,(unknown),Gilda F. Linton,Harry L. Malech	13
6	Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency 2007 ·Blood ·Javier Chinen,Joie Davis,Suk See De Ravin,Beverly N. Hay,Amy P. Hsu,Gilda F. Linton,Nora Naumann,Effie Nomicos,Christopher Silvin,Jean Ulrick,Narda Whiting‐Theobald,Harry L. Malech,Jennifer M. Puck	63
7	Polyclonal Long-Term MFGS-gp91phox Marking in Rhesus Macaques after Nonmyeloablative Transplantation with Transduced Autologous Peripheral Blood Progenitor Cells 2006 ·Molecular Therapy ·Sebastian Brenner,Martin Ryser,Uimook Choi,Narda Whiting‐Theobald,Eberhard Kuhlisch,Gilda F. Linton,Elizabeth M. Kang,(unknown),Angela Rösen‐Wolff,(unknown),Ann M. Farese,Thomas J. MacVittie,Joachim Roesler,Mitchell E. Horwitz,Harry L. Malech	8
8	WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus–truncated CXCR4 2006 ·Blood ·Toshinao Kawai,Uimook Choi,(unknown),Suk See De Ravin,Nora Naumann,Narda Whiting‐Theobald,Gilda F. Linton,(unknown),Philip M. Murphy,Harry L. Malech	61
9	Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome 2005 ·Experimental Hematology ·Toshinao Kawai,Uimook Choi,Narda Whiting‐Theobald,Gilda F. Linton,Sebastian Brenner,Joan M. G. Sechler,Philip M. Murphy,Harry L. Malech	69
10	Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy 2005 ·Blood ·(unknown),(unknown),Nora Naumann,Jeffrey S. Kennedy,Uimook Choi,(unknown),Gilda F. Linton,Narda Whiting‐Theobald,Peter F. Moore,William Vernau,Harry L. Malech,Peter J. Felsburg	33
11	Nuclear-localizing O6-benzylguanine-resistant GFP-MGMT fusion protein as a novel in vivo selection marker 2004 ·Experimental Hematology ·Uimook Choi,Suk See De Ravin,Kouhei Yamashita,Narda Whiting‐Theobald,Gilda F. Linton,Natalia A. Loktionova,Anthony E. Pegg,Harry L. Malech	9
12	CXCR4‐Transgene Expression Significantly Improves Marrow Engraftment of Cultured Hematopoietic Stem Cells 2004 ·Stem Cells ·Sebastian Brenner,Narda Whiting‐Theobald,Toshinao Kawai,Gilda F. Linton,(unknown),Uimook Choi,Martin Ryser,Philip M. Murphy,Joan M. G. Sechler,Harry L. Malech	94
13	Third-generation, self-inactivating gp91phoxlentivector corrects the oxidase defect in NOD/SCID mouse–repopulating peripheral blood–mobilized CD34+ cells from patients with X-linked chronic granulomatous disease 2002 ·Blood ·Joachim Roesler,Sebastian Brenner,Antonín Bukovský,Narda Whiting‐Theobald,Thomas J. Dull,Michael T. Kelly,Curt I. Civin,Harry L. Malech	51
14	Efficient and Durable Gene Marking of Hematopoietic Progenitor Cells in Nonhuman Primates After Nonablative Conditioning 1999 ·Blood ·Michael Rosenzweig,Thomas J. MacVittie,David M. Harper,Donna Hempel,Rhona L. Glickman,R. Paul Johnson,Ann M. Farese,Narda Whiting‐Theobald,Gilda F. Linton,Glenn Yamasaki,Craig T. Jordan,Harry L. Malech	86
15	Genetic Correction of p67phox Deficient Chronic Granulomatous Disease Using Peripheral Blood Progenitor Cells as a Target for Retrovirus Mediated Gene Transfer 1997 ·Blood ·(unknown),Gilda F. Linton,Narda Whiting‐Theobald,Sarah J. Vowells,Steven P. Rafferty,Fei Li,Harry L. Malech	3
16	Genetic Correction of p67phox Deficient Chronic Granulomatous Disease Using Peripheral Blood Progenitor Cells as a Target for Retrovirus Mediated Gene Transfer 1997 ·Blood ·(unknown),Gilda F. Linton,Narda Whiting‐Theobald,Sarah J. Vowells,Steven P. Rafferty,Fei Li,Harry L. Malech	33
17	A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression 1996 ·Blood ·Robert Sokolic,Sudhir Sekhsaria,Y. Sugimoto,Narda Whiting‐Theobald,(unknown),(unknown),M M Gottesman,Harry L. Malech	1
18	A bicistronic retrovirus vector containing a picornavirus internal ribosome entry site allows for correction of X-linked CGD by selection for MDR1 expression 1996 ·Blood ·Robert Sokolic,Sudhir Sekhsaria,Y. Sugimoto,Narda Whiting‐Theobald,(unknown),(unknown),M M Gottesman,Harry L. Malech	48
19	CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease 1994 ·Blood ·(unknown),(unknown),Sudhir Sekhsaria,Narda Whiting‐Theobald,(unknown),JI Gallin,Harry L. Malech	63
20	CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease 1994 ·Blood ·(unknown),(unknown),Sudhir Sekhsaria,Narda Whiting‐Theobald,(unknown),JI Gallin,Harry L. Malech	8

About Narda Whiting‐Theobald

Narda Whiting‐Theobald is a scholar working on Oncology, Genetics and Immunology, having authored 20 papers that have together received 779 indexed citations. Recurring topics across this work include Virus-based gene therapy research (14 papers), CAR-T cell therapy research (10 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Immunology (340 citations), Genetics (370 citations) and Oncology (321 citations). Narda Whiting‐Theobald has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Harry L. Malech, Gilda F. Linton, Uimook Choi, Toshinao Kawai, Sebastian Brenner, Philip M. Murphy, Suk See De Ravin, Joan M. G. Sechler, Nora Naumann and Sudhir Sekhsaria. Their work appears in journals such as Blood, Stem Cells and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact